4.4 Review

3D bioprinting of stem cell-laden cardiac patch: A promising alternative for myocardial repair

Journal

APL BIOENGINEERING
Volume 5, Issue 3, Pages -

Publisher

AIP Publishing
DOI: 10.1063/5.0030353

Keywords

-

Funding

  1. Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2020R1A6A1A03047902]
  2. National Research Foundation of Korea (NRF) - Korea government (MSIT) [2021R1A2C2004981]
  3. Ministry of Trade, Industry, and Energy (MOTIE) through the International Cooperative RD program [P0011282_3D]
  4. Korea Institute for Advancement of Technology (KIAT) through the International Cooperative RD program [P0011282_3D]
  5. National Research Foundation of Korea [2021R1A2C2004981] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

Stem cell-laden three-dimensional bioprinted cardiac patches show promise in treating ischemic cardiomyopathy by reversing scar formation and promoting myocardial regeneration, but face challenges in achieving consistent results.
Stem cell-laden three-dimensional (3D) bioprinted cardiac patches offer an alternative and promising therapeutic and regenerative approach for ischemic cardiomyopathy by reversing scar formation and promoting myocardial regeneration. Numerous studies have reported using either multipotent or pluripotent stem cells or their combination for 3D bioprinting of a cardiac patch with the sole aim of restoring cardiac function by faithfully rejuvenating the cardiomyocytes and associated vasculatures that are lost to myocardial infarction. While many studies have demonstrated success in mimicking cardiomyocytes' behavior, improving cardiac function and providing new hope for regenerating heart post-myocardial infarction, some others have reported contradicting data in apparent ways. Nonetheless, all investigators in the field are speed racing toward determining a potential strategy to effectively treat losses due to myocardial infarction. This review discusses various types of candidate stem cells that possess cardiac regenerative potential, elucidating their applications and limitations. We also brief the challenges of and an update on the implementation of the state-of-the-art 3D bioprinting approach to fabricate cardiac patches and highlight different strategies to implement vascularization and augment cardiac functional properties with respect to electrophysiological similarities to native tissue. (C) 2021 Author(s). All article content, except where otherwise noted, is licensed under a Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available